Clinical Trial Update: Study of the Efficacy and Safety of Tezosentan in Patients With Pre-operative Pulmonary Hypertension, Due to Left Heart Disease, Undergoing Open Heart Surgery [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating the efficacy and safety of tezosentan in patients with pre-operative pulmonary hypertension due to left heart disease undergoing open…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Disease
• Pulmonary Hypertension

Drugs mentioned

• Tezosentan (tezosentan)

Snippet

Sponsor: Idorsia Pharmaceuticals Ltd. | Conditions: Heart Diseases, Hypertension, Pulmonary | Phase 3 | Status: TERMINATED